| Overall survival | Distant disease-free survival | ||||
---|---|---|---|---|---|---|
 | HR | 95% CI | P | HR | 95% CI | P |
pT2 + pT3 | 1.68 | 1.12 to 2.52 | 0.01 | 1.61 | 1.14 to 2.25 | 0.006 |
pN + | 2.62 | 1.31 to 5.23 | 0.006 | 2.21 | 1.24 to 3.96 | 0.008 |
Lymphangio invasion | Â | Â | 0.75 | Â | Â | 0.73 |
   No vessels | 1 |  |  | 1 |  |  |
   1 to 5 vessels | 0.93 | 0.53 to 1.62 |  | 0.97 | 0.61 to 1.53 |  |
   > 5 vessels | 1.18 | 0.71 to 1.97 |  | 1.17 | 0.75 to 1.83 |  |
Molecular subtype | Â | Â | 0.02 | Â | Â | 0.06 |
   Basal | 1 |  |  | 1 |  |  |
   Luminal A | 0.50 | 0.29 to 0.86 |  | 0.69 | 0.44 to 1.08 |  |
   HER2 | 0.42 | 0.17 to 1.04 |  | 0.45 | 0.21 to 0.99 |  |
   Luminal B | 0.92 | 0.56 to 1.48 |  | 1.01 | 0.67 to 1.53 |  |
Breast conserving therapy | 0.76 | 0.47 to 1.24 | 0.27 | 0.81 | 0.53 to 1.23 | 0.33 |
Adjuvant chemotherapy | 0.68 | 0.35 to 1.33 | 0.26 | 0.65 | 0.37 to 1.13 | 0.13 |